Skip to main navigation Skip to search Skip to main content

Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2527-2530
Number of pages4
JournalLeukemia
Volume33
Issue number10
DOIs
StatePublished - Oct 1 2019

Cite this